BioRegenx, Inc.
BRGX
$0.01
$0.0041.11%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.93M | -19.24M | -20.17M | -23.05M | -4.91M |
| Total Depreciation and Amortization | 611.70K | 1.20M | 1.73M | 2.22M | 1.65M |
| Total Amortization of Deferred Charges | 41.60K | 23.20K | 38.00K | 47.70K | 33.40K |
| Total Other Non-Cash Items | 17.93M | 17.59M | 17.73M | 19.93M | 2.54M |
| Change in Net Operating Assets | 299.50K | 430.90K | 484.80K | 530.60K | 137.60K |
| Cash from Operations | -42.10K | -1.70K | -182.20K | -324.20K | -558.40K |
| Capital Expenditure | -6.00K | 0.00 | 0.00 | -189.40K | -189.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | 1.40K | 1.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.30K | -47.30K | 2.70K | 0.00 | -202.10K |
| Cash from Investing | -53.30K | -47.30K | 2.70K | -187.90K | -390.00K |
| Total Debt Issued | 149.00K | 88.30K | 190.40K | 490.40K | 491.50K |
| Total Debt Repaid | -78.80K | -42.40K | -41.20K | -48.20K | -56.10K |
| Issuance of Common Stock | -- | -- | -- | -- | 527.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 70.30K | 45.90K | 149.20K | 442.20K | 962.50K |
| Foreign Exchange rate Adjustments | 1.90K | -7.90K | -200.00 | 2.90K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.20K | -11.00K | -30.60K | -67.00K | 12.10K |